News

An opioid made in the brain is crucial for remembering others

Without enkephalin, a neuropeptide, mice were unable to recognize other mice they’d already met
Czarina Ramos
By Czarina Ramos
Aug. 7, 2021

It would be inconvenient if we couldn’t remember the people we have or haven’t met before. Social recognition, the ability to differentiate familiar or novel individuals of the same species is part of a larger process of social memory that allows groups within a species to build and maintain stable networks or relationships, like what we know as friend groups or communities.

Enkephalin-445x297.jpg

The hippocampus, known for its role in memory, is divided into subregions that contribute to different memory processes, and one called CA2 is particularly important for social memory. Scientists have found one particular neurochemical to be important in social recognition. Enkephalin, a neuropeptide that interacts with opioid receptors, is needed in CA2 to recognize new people.

Enkephalins belong to a class of opioids produced by the brain which are often associated with stress response and pain relief. The researchers found that in CA2, these compounds are released by specific type of neuron, boosting information transfer to the CA2, thus enabling our brains to form social memories.

A better understanding of social memory can help demystify related diseases

Scientists studied the effects of enkephalin through a social memory test in mice. They introduced one mouse to a space with two others, and the subject mouse was allowed to interact with each mouse for fiver minutes. The subject mouse was removed, then returned half an hour later, this time with one of the mice from the last entry and one mouse it had not met before. The typical response for mice in this case is to pay attention to the new mouse for longer. The scientists observed that, while mice with regular enkephalin levels sniffed out the new mouse for a longer amount of time, mice without enkephalin spent the same amount of time between both mice, as if they had not previously encountered one of them.

A better understanding of social memory can help demystify related diseases. Schizophrenia, a condition in which social memory is impaired, is treated with drugs affecting opioid receptors, for example. The results of this study shed light on how these treatments work.

This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Czarina Ramos
Czarina Ramos

Czarina Ramos is a graduate researcher at Albert Einstein College of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Teaching AI to listen
Essay

Teaching AI to listen

Sept. 18, 2025

A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Journal News

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder

Sept. 16, 2025

Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Journal News

How sugars shape Marfan syndrome

Sept. 10, 2025

Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.